174 related articles for article (PubMed ID: 15223728)
1. Effects of losartan versus hydrochlorothiazide on indices of endothelial damage/dysfunction, angiogenesis and tissue factor in essential hypertension.
Chung NA; Beevers DG; Lip G
Blood Press; 2004; 13(3):183-9. PubMed ID: 15223728
[TBL] [Abstract][Full Text] [Related]
2. [The effectiveness and tolerability of losartan and effect on left ventricular mass in patients with essential hypertension].
Tedesco MA; Ratti G; Aquino D; Caccavale A; Acitorio M; Rocereto A; Cosimi R; Coppolino P; Iarussi D; Iacono A
Cardiologia; 1998 Jan; 43(1):53-9. PubMed ID: 9534293
[TBL] [Abstract][Full Text] [Related]
3. Comparison of fixed-dose combinations of telmisartan/hydrochlorothiazide 40/12.5 mg and 80/12.5 mg and a fixed-dose combination of losartan/hydrochlorothiazide 50/12.5 mg in mild to moderate essential hypertension: pooled analysis of two multicenter, prospective, randomized, open-label, blinded-end point (PROBE) trials.
Lacourcière Y; Neutel JM; Schumacher H
Clin Ther; 2005 Nov; 27(11):1795-805. PubMed ID: 16368450
[TBL] [Abstract][Full Text] [Related]
4. Fixed-dose combination of losartan and hydrochlorothiazide significantly improves endothelial function in uncontrolled hypertension by low-dose amlodipine: a randomized study.
Takase B; Nagata M
Anadolu Kardiyol Derg; 2014 Dec; 14(8):685-91. PubMed ID: 25341478
[TBL] [Abstract][Full Text] [Related]
5. Physical activity in relation to indices of endothelial function and angiogenesis factors in hypertension: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT).
Felmeden DC; Spencer CG; Blann AD; Beevers DG; Lip GY
J Intern Med; 2003 Jan; 253(1):81-91. PubMed ID: 12588540
[TBL] [Abstract][Full Text] [Related]
6. Inter-relationships of indices of endothelial damage/dysfunction [circulating endothelial cells, von Willebrand factor and flow-mediated dilatation] to tissue factor and interleukin-6 in acute coronary syndromes.
Lee KW; Blann AD; Lip GY
Int J Cardiol; 2006 Aug; 111(2):302-8. PubMed ID: 16324758
[TBL] [Abstract][Full Text] [Related]
7. Comparison of antihypertensive and metabolic effects of losartan and losartan in combination with hydrochlorothiazide--a randomized controlled trial.
Owens P; Kelly L; Nallen R; Ryan D; Fitzgerald D; O'Brien E
J Hypertens; 2000 Mar; 18(3):339-45. PubMed ID: 10726721
[TBL] [Abstract][Full Text] [Related]
8. Effects of barnidipine in comparison with hydrochlorothiazide on endothelial function, as assessed by flow mediated vasodilatation in hypertensive patients.
Muiesan ML; Salvetti M; Belotti E; Paini A; Rosei CA; Aggiusti C; Scotti A; de Ciuceis C; Rizzoni D; Rosei EA
Blood Press; 2011 Aug; 20(4):244-51. PubMed ID: 21332412
[TBL] [Abstract][Full Text] [Related]
9. Effect of combination therapy with the angiotensin receptor blocker losartan plus hydrochlorothiazide on brain perfusion in patients with both hypertension and cerebral hemodynamic impairment due to symptomatic chronic major cerebral artery steno-occlusive disease: a SPECT study.
Saura H; Ogasawara K; Suzuki T; Kuroda H; Yamashita T; Kobayashi M; Terasaki K; Ogawa A
Cerebrovasc Dis; 2012; 33(4):354-61. PubMed ID: 22433127
[TBL] [Abstract][Full Text] [Related]
10. Telmisartan vs losartan plus hydrochlorothiazide in the treatment of mild-to-moderate essential hypertension--a randomised ABPM study.
Neutel JM; Kolloch RE; Plouin PF; Meinicke TW; Schumacher H;
J Hum Hypertens; 2003 Aug; 17(8):569-75. PubMed ID: 12874615
[TBL] [Abstract][Full Text] [Related]
11. Relation of thrombogenesis in systemic hypertension to angiogenesis and endothelial damage/dysfunction (a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial [ASCOT]).
Felmeden DC; Spencer CG; Chung NA; Belgore FM; Blann AD; Beevers DG; Lip GY
Am J Cardiol; 2003 Aug; 92(4):400-5. PubMed ID: 12914869
[TBL] [Abstract][Full Text] [Related]
12. [Efficacy and safety of combination therapy with losartan and hydrochlorothiazide in elderly hypertension].
Eto K; Tsuchihashi T; Abe I; Iida M
Nihon Ronen Igakkai Zasshi; 2002 Mar; 39(2):181-6. PubMed ID: 11974942
[TBL] [Abstract][Full Text] [Related]
13. Fixed-dose telmisartan/hydrochlorothiazide in comparison with losartan/hydrochlorothiazide in decreasing serum hepatocyte growth factor and improving endothelial dysfunction in hypertensive patients.
Hu ZP; Wang BN; Qian HY; Zhou Q; Wei W; Wang Y
Int Heart J; 2010 Jul; 51(4):252-8. PubMed ID: 20716842
[TBL] [Abstract][Full Text] [Related]
14. Ambulatory monitoring of systolic hypertension in the elderly: Eprosartan/hydrochlorothiazide compared with losartan/hydrochlorothiazide (INSIST trial).
Ambrosioni E; Bombelli M; Cerasola G; Cipollone F; Ferri C; Grazioli I; Leprotti C; Mancia G; Melzi G; Mugellini A; Mulè G; Palasciano G; Salvetti A; Trimarco B
Adv Ther; 2010 Jun; 27(6):365-80. PubMed ID: 20556561
[TBL] [Abstract][Full Text] [Related]
15. [Possibilities of using indices of vascular wall function as markers of negative metabolic effects of treatment with thiazide diuretics in patients with essential hypertension].
Semenkin AA
Ter Arkh; 2007; 79(4):31-8. PubMed ID: 17564015
[TBL] [Abstract][Full Text] [Related]
16. Adding thiazide to a renin-angiotensin blocker improves left ventricular relaxation and improves heart failure in patients with hypertension.
Ito H; Ishii K; Kihara H; Kasayuki N; Nakamura F; Shimada K; Fukuda S; Iwakura K; Yoshikawa J;
Hypertens Res; 2012 Jan; 35(1):93-9. PubMed ID: 22011686
[TBL] [Abstract][Full Text] [Related]
17. Aliskiren reduces blood pressure and suppresses plasma renin activity in combination with a thiazide diuretic, an angiotensin-converting enzyme inhibitor, or an angiotensin receptor blocker.
O'Brien E; Barton J; Nussberger J; Mulcahy D; Jensen C; Dicker P; Stanton A
Hypertension; 2007 Feb; 49(2):276-84. PubMed ID: 17159081
[TBL] [Abstract][Full Text] [Related]
18. Combination angiotensin receptor blocker/hydrochlorothiazide as initial therapy in the treatment of patients with severe hypertension.
Salerno CM; Demopoulos L; Mukherjee R; Gradman AH
J Clin Hypertens (Greenwich); 2004 Nov; 6(11):614-20. PubMed ID: 15538094
[TBL] [Abstract][Full Text] [Related]
19. Plasma VEGF and soluble VEGF receptor FLT-1 in proliferative retinopathy: relationship to endothelial dysfunction and laser treatment.
Lip PL; Belgore F; Blann AD; Hope-Ross MW; Gibson JM; Lip GY
Invest Ophthalmol Vis Sci; 2000 Jul; 41(8):2115-9. PubMed ID: 10892852
[TBL] [Abstract][Full Text] [Related]
20. Endothelial damage and angiogenesis in hypertensive patients: relationship to cardiovascular risk factors and risk factor management.
Felmeden DC; Spencer CG; Belgore FM; Blann AD; Beevers DG; Lip GY
Am J Hypertens; 2003 Jan; 16(1):11-20. PubMed ID: 12517677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
